The complete list of late-breaking clinical science to be presented at THT 2024: Technology and Heart Failure Therapeutics is now available online. An internat
The complete list of late-breaking clinical science to be presented at THT 2024: Technology and Heart Failure Therapeutics is now available online. An internat
/PRNewswire/ BioVentrix®, Inc., a privately held medical device company focused on the development of less invasive therapies to directly treat the dilated.